Angiotensin Receptor Blockers Don't Seem to Increase Risk of MI

BMJ
doi 10.1136/bmj.331.7521.0-a
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

BMJ

Related search

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Angiotensin Receptor Blockers: Rational Prescription Tailored to the Cardiovascular Risk and Comorbidities

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Receptor Blockers Use and the Risk of Lung Cancer: A Meta-Analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2015English

The Potential Economic Impact of Restricted Access to Angiotensin-Receptor Blockers

CMAJ
Medicine
2011English

The Effect of Angiotensin II Receptor Blockers on Hyperuricemia

Therapeutic Advances in Chronic Disease
Medicine
2015English

Polymorphisms of the Angiotensin II Type 1 Receptor Gene Affect Antihypertensive Response to Angiotensin Receptor Blockers in Hypertensive Chinese

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Are the Eutrophic Effects of Angiotensin Receptor Blockers Real?

Hypertension
Internal Medicine
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy